Literature DB >> 25330222

Allogeneic hematopoietic cell transplantation for concurrent multiple myeloma and myelodysplastic syndrome.

T Nishihori1, R Komrokji2, K Shain2, C Anasetti1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25330222     DOI： 10.1038/bmt.2014.233

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  9 in total

1.  Simultaneous occurrence of the 5q- syndrome and multiple myeloma.

Authors:  R Rios; F Sole; F Gascon
Journal:  Clin Lab Haematol       Date:  2000-02

2.  Co-occurrence of monoclonal gammopathy and myelodysplasia: a retrospective study of fourteen cases.

Authors:  Yataro Yoshida; Shigeru Oguma; Hitoshi Ohno; Yukiharu Nakabo; Tatsuya Katsurada; Masahiro Kawahara; Hiroshi Kawabata
Journal:  Int J Hematol       Date:  2014-04-01       Impact factor: 2.490

3.  Incidence and characteristics of lymphoid malignancies in untreated myelodysplastic syndromes.

Authors:  L Florensa; T Vallespí; S Woessner; A Domingo; N Crespo; M Rozman; J L Aguilar; D Irriguible; A Zarco; F Millá; E Feliu
Journal:  Leuk Lymphoma       Date:  1996-11

4.  Multiple myeloma and acute myelomonocytic leukemia.

Authors:  R A Kyle; R V Pierre; E D Bayrd
Journal:  N Engl J Med       Date:  1970-11-19       Impact factor: 91.245

5.  5q- syndrome and multiple myeloma diagnosed simultaneously and successful treated with lenalidomide.

Authors:  Margarita Ortega; Mar Mallo; Francesc Solé; Carmen Sánchez-Morata; Laura López-Andreoni; Noemí Martínez-Morgado; Mercedes Gironella; David Valcárcel; Teresa Vallespí
Journal:  Leuk Res       Date:  2013-07-26       Impact factor: 3.156

6.  Lenalidomide after stem-cell transplantation for multiple myeloma.

Authors:  Philip L McCarthy; Kouros Owzar; Craig C Hofmeister; David D Hurd; Hani Hassoun; Paul G Richardson; Sergio Giralt; Edward A Stadtmauer; Daniel J Weisdorf; Ravi Vij; Jan S Moreb; Natalie Scott Callander; Koen Van Besien; Teresa Gentile; Luis Isola; Richard T Maziarz; Don A Gabriel; Asad Bashey; Heather Landau; Thomas Martin; Muzaffar H Qazilbash; Denise Levitan; Brian McClune; Robert Schlossman; Vera Hars; John Postiglione; Chen Jiang; Elizabeth Bennett; Susan Barry; Linda Bressler; Michael Kelly; Michele Seiler; Cara Rosenbaum; Parameswaran Hari; Marcelo C Pasquini; Mary M Horowitz; Thomas C Shea; Steven M Devine; Kenneth C Anderson; Charles Linker
Journal:  N Engl J Med       Date:  2012-05-10       Impact factor: 91.245

7.  Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome.

Authors:  Wanlong Ma; Hagop Kantarjian; Ke Zhang; Xi Zhang; Xiuqiang Wang; Clifford Chen; Amber C Donahue; Zhong Zhang; Chen-Hsiung Yeh; Susan O'Brien; Guillermo Garcia-Manero; Neil Caporaso; Ola Landgren; Maher Albitar
Journal:  BMC Med Genet       Date:  2010-11-16       Impact factor: 2.103

8.  Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and concurrent lymphoid malignancy.

Authors:  Z Zimmerman; B L Scott; A K Gopal; B M Sandmaier; D G Maloney; H J Deeg
Journal:  Bone Marrow Transplant       Date:  2011-09-12       Impact factor: 5.483

9.  A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors.

Authors:  Carolina Vicente-Dueñas; Isabel Romero-Camarero; Inés González-Herrero; Esther Alonso-Escudero; Fernando Abollo-Jiménez; Xiaoyu Jiang; Norma C Gutierrez; Alberto Orfao; Nieves Marín; Luisa María Villar; Ma Carmen Fernández Criado; Belén Pintado; Teresa Flores; Diego Alonso-López; Javier De Las Rivas; Rafael Jiménez; Francisco Javier García Criado; María Begoña García Cenador; Izidore S Lossos; César Cobaleda; Isidro Sánchez-García
Journal:  EMBO J       Date:  2012-08-17       Impact factor: 11.598
  9 in total
  1 in total

1.  Reply to 'allogeneic hematopoietic cell transplantation for concurrent multiple myeloma and myelodysplastic syndrome'.

Authors:  T Schroeder; R Fenk; R Haas; U Germing; G Kobbe
Journal:  Bone Marrow Transplant       Date:  2015-08-03       Impact factor: 5.483
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.